Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3185
Selected: 0
NCT IDTitle
NCT04169737Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
NCT03441061Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
NCT01701986Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
NCT01159236Molecular Triaging of Newly Diagnosed Breast Cancer
NCT02458014Blinatumomab in Treating Patients With B-cell Acute Lymphoblastic Leukemia With Minimal Residual Disease
NCT02263014Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM)
NCT01000051Eltrombopag for Post Transplant Thrombocytopenia
NCT05294302Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
NCT04119037Cordotomy in Reducing Pain in Patients With Advanced Cancer
NCT05744557Vapocoolant Analgesia for Breast Lymphoscintigraphy
NCT04560712Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery
NCT05317936Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With Venetoclax
NCT00430872Development of the MDASI-Spine Tumor Module
NCT04493164CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
NCT05064787Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
NCT00941395Enhanced Smoking Cessation for University Students
NCT00038844Safety and Efficacy of Campath in Nonmyeloablative Transplantation
NCT00488644Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
NCT00671801Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I
NCT05733091Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors
NCT06036810Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
NCT04745910Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome
NCT02473042Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)
NCT00562770Oral Valganciclovir Versus Valacyclovir
NCT02807883Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia
NCT04054154An Investigational Device (Millar Mikro-Tip Catheter) and Imaging Scan (Shear Wave Elastography) in Measuring Tumor Pressure and Stiffness in Patients With Solid Tumors Undergoing Ultrasound-Guided Biopsy
NCT01512589Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial
NCT01492673Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma
NCT02784496Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis
NCT00939159Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
NCT04228042Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer
NCT04075305The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT00539227A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy
NCT04266886Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer
NCT02629809Ibrutinib, Fludarabine Phosphate, Cyclophosphamide, and Obinutuzumab in Treating Patients With Chronic Lymphocytic Leukemia
NCT05091632Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care Unit
NCT004220322 Arm Study of Clofarabine IV in MDS Patients
NCT01788787Ask Advise Connect (AAC) Harris Heath CPRIT
NCT01417065Temsirolimus In Phase 0
NCT03926507F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
NCT01057264HAI Abraxane With Gemcitabine and Bevacizumab
NCT05536349Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
NCT00508378Chemotherapy-Related Toxicities In Ovarian Cancer Patients
NCT03195699Oral STAT3 Inhibitor, TTI-101, in Patients with Advanced Cancers
NCT03809130Effectiveness of an Online Intervention Targeting Cancer-related Fatigue
NCT01339871Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies
NCT00960544Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism
NCT00506467Vibration Response Imaging (VRI) in Lung Cancer Patients
NCT02911064Expectations Regarding Mobility and Self-Care
NCT03698552ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia